Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn C Hartmann

Showing results (21-30 of 147) with videos related to

Pageof 15
Sort By:
Immunotherapy|April 6, 2011
Immunity and immune suppression in human ovarian cancerClaudia C Preston, Ellen L Goode, Lynn C Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
Reply to M.H. Gail et alV Shane Pankratz, Amy C Degnim, Robert A Vierkant, et al.
Journal of Cellular Biochemistry|September 21, 2007
Molecular pathogenesis and therapeutic targets in epithelial ovarian cancerJeremy R Chien, Giovanni Aletti, Debra A Bell, et al.
Minnesota Medicine|November 11, 2006
Helping people cope with bereavement: an opportunity for health care providers to link Web-based resources across MinnesotaAminah Jatoi, Jane A Jacobs, Elizabeth Zimmermann, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 20, 2012
Fracture risk in women with breast cancer: a population-based studyL Joseph Melton, Lynn C Hartmann, Sara J Achenbach, et al.
Cancer Research|August 17, 2002
Intraperitoneal therapy of ovarian cancer using an engineered measles virusKah-Whye Peng, Cynthia J TenEyck, Evanthia Galanis, et al.
AJR. American Journal of Roentgenology|May 30, 2002
MR elastography of breast cancer: preliminary resultsAlexia L McKnight, Jennifer L Kugel, Phillip J Rossman, et al.
Annals of Surgical Oncology|September 28, 2011
Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traitsMarlene H Frost, Tanya L Hoskin, Lynn C Hartmann, et al.
American Journal of Obstetrics and Gynecology|June 18, 2002
Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV cervical cancerSean C Dowdy, Cecelia H Boardman, Timothy O Wilson, et al.
Breast Cancer Research and Treatment|July 27, 2015
Breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomesRobert W Mutter, Marlene H Frost, Tanya L Hoskin, et al.
Pageof 15

Showing results (21-30 of 147) with videos related to

Sort By:
Pageof 15
Immunotherapy|April 6, 2011
Immunity and immune suppression in human ovarian cancerClaudia C Preston, Ellen L Goode, Lynn C Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
Reply to M.H. Gail et alV Shane Pankratz, Amy C Degnim, Robert A Vierkant, et al.
Journal of Cellular Biochemistry|September 21, 2007
Molecular pathogenesis and therapeutic targets in epithelial ovarian cancerJeremy R Chien, Giovanni Aletti, Debra A Bell, et al.
Minnesota Medicine|November 11, 2006
Helping people cope with bereavement: an opportunity for health care providers to link Web-based resources across MinnesotaAminah Jatoi, Jane A Jacobs, Elizabeth Zimmermann, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 20, 2012
Fracture risk in women with breast cancer: a population-based studyL Joseph Melton, Lynn C Hartmann, Sara J Achenbach, et al.
Cancer Research|August 17, 2002
Intraperitoneal therapy of ovarian cancer using an engineered measles virusKah-Whye Peng, Cynthia J TenEyck, Evanthia Galanis, et al.
AJR. American Journal of Roentgenology|May 30, 2002
MR elastography of breast cancer: preliminary resultsAlexia L McKnight, Jennifer L Kugel, Phillip J Rossman, et al.
Annals of Surgical Oncology|September 28, 2011
Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traitsMarlene H Frost, Tanya L Hoskin, Lynn C Hartmann, et al.
American Journal of Obstetrics and Gynecology|June 18, 2002
Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV cervical cancerSean C Dowdy, Cecelia H Boardman, Timothy O Wilson, et al.
Breast Cancer Research and Treatment|July 27, 2015
Breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomesRobert W Mutter, Marlene H Frost, Tanya L Hoskin, et al.
Pageof 15